dorsaVi Ltd

dorsaVi's capital structure is characterized by a low debt-to-equity ratio of 0.06, indicating a conservative leverage profile, and a strong current ratio of 3.3, suggesting robust short-term liquidity. The company holds $2.29 million in cash and equivalents, which is a significant portion of its total assets of $3.97 million, further reinforcing its liquidity position. Profitability metrics reveal a challenging operating environment, with a negative return on equity of -53.52% and a return on assets of -38.22%. These figures indicate that the company is not generating returns for shareholders or effectively utilizing its assets to produce profit. Gross profit of $971,820 is offset by a significant operating loss of $1.88 million, resulting in a net loss of $1.52 million. The company's revenue is derived from two segments: Clinical and Workplace. While the input data does not provide specific revenue breakdowns by segment, the product offerings suggest a diversified approach across clinical, sports, and occupational health markets. However, the lack of geographic revenue concentration data limits the ability to assess exposure to regional economic risks. Growth trajectory appears constrained, with the company reporting a net loss and negative operating and free cash flows. The absence of revenue growth data and the current financial performance suggest that the company is in a development or expansion phase rather than a mature growth stage. The capital expenditure of $304,000 indicates ongoing investment in infrastructure or product development. Risk factors include a low liquidity risk and a low dilution potential, with no immediate filing-based liquidity or dilution flags detected. The company's low debt levels and strong cash position mitigate liquidity concerns, while the absence of dilution risk suggests a stable capital structure. No recent events such as filings or transcripts have been disclosed that would significantly impact the company's risk profile.